---
title: "Bridgebio Pharma (BBIO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BBIO.US/norm.md"
symbol: "BBIO.US"
name: "Bridgebio Pharma"
parent: "https://longbridge.com/en/quote/BBIO.US.md"
datetime: "2026-05-20T03:33:35.446Z"
locales:
  - [en](https://longbridge.com/en/quote/BBIO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BBIO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BBIO.US/norm.md)
---

# Bridgebio Pharma (BBIO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.8422 | -0.9964 | -0.9525 | -0.9548 | -0.8805 |
| ROE | 30.07% | 38.38% | 39.29% | 42.35% | 42.98% |
| Revenue | 194.51M | 154.18M | 120.70M | 110.56M | 116.63M |
| Net income | -164.04M | -192.86M | -182.74M | -181.90M | -167.42M |
| Operating income | -105.96M | -128.43M | -136.36M | -133.47M | -103.80M |
| Gross margin | 94.89% | 94.74% | 94.56% | 96.70% | 97.74% |
| Net margin | -84.33% | -125.09% | -151.40% | -164.52% | -143.55% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.37B | 936.02M | 998.25M | 1.08B | 881.64M |
| Leverage | -0.6043 | -0.4508 | -0.5192 | -0.6074 | -0.5380 |
| BVPS | -11.64 | -10.71 | -10.04 | -9.35 | -8.68 |
| Turnover | 0.5149 | 0.5412 | 0.4254 | 0.2516 | 0.1472 |
| Cash & STI | 940.19M | 587.48M | 645.94M | 756.89M | 540.60M |
| Inv & Rec | 32.98M | 26.75M | 24.53M | 18.28M | 3.95M |
| LT assets | 22.17M | 13.52M | 12.38M | 12.29M | 13.86M |
| Net debt | 1.55B | 1.27B | 1.21B | 1.10B | 1.32B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -197.28M | -56.42M | -109.57M | -80.68M | -199.24M |
| Investing CF | -42.73M | -14.35M | 4.46M | -13.00M | -1.59M |
| Financing CF | 549.89M | -2.18M | -894000.00 | 302.04M | 60.33M |
| Free CF | -139.92M | 9.67M | -49.25M | -26.49M | -153.78M |
| OCF coverage | -285911.59% | -170969.70% | -23313.62% | -13582.66% | -43.41% |
| Repaid & issued | 632.50M | 0.0000 | 0.0000 | 300.00M | 575.00M |
| CapEx | -69000.00 | -33000.00 | -470000.00 | -594000.00 | - |